Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
British Journal of Clinical Pharmacology
|
February 3, 2026
Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance
Michiel A Damhof, Lisanne N van Merendonk, Marco B Polee, et al.
Therapeutic Drug Monitoring
|
January 30, 2022
Everolimus Concentration in Saliva to Predict Stomatitis: A Feasibility Study in Patients with Cancer
Laura Molenaar-Kuijsten, Remy B Verheijen, Bart A W Jacobs, et al.
European Journal of Clinical Pharmacology
|
February 13, 2018
The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases
Bart A W Jacobs, Nikol Snoeren, Morsal Samim, et al.
Frontiers in Pharmacology
|
March 17, 2023
Access to medicines for rare diseases: A European regulatory roadmap for academia
Noa Rosenberg, Sibren van den Berg, Nina N Stolwijk, et al.
Cancer Chemotherapy and Pharmacology
|
March 1, 2024
Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data
Cedric Lau, Ma Ida Mohmaed Ali, Lishi Lin, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 26, 2019
Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis
Bart A W Jacobs, Maarten J Deenen, Markus Joerger, et al.
Journal of Inherited Metabolic Disease
|
March 7, 2026
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis
Natalja Bouwhuis, Soumia Majait, Yasmin Polak, et al.
Cancer Chemotherapy and Pharmacology
|
April 23, 2016
A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine
Bart A W Jacobs, Jelte Meulenaar, Hilde Rosing, et al.
Pharmaceutical Research
|
May 9, 2020
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Jeroen Roosendaal, Bart A W Jacobs, Dick Pluim, et al.
Bioanalysis
|
April 1, 2015
Improved pharmacodynamic assay for dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells
Dick Pluim, Bart A W Jacobs, Maarten J Deenen, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
British Journal of Clinical Pharmacology
|
February 3, 2026
Clinical response to capecitabine in a DPYD*2A homozygous patient: Case report and therapeutic guidance
Michiel A Damhof, Lisanne N van Merendonk, Marco B Polee, et al.
Therapeutic Drug Monitoring
|
January 30, 2022
Everolimus Concentration in Saliva to Predict Stomatitis: A Feasibility Study in Patients with Cancer
Laura Molenaar-Kuijsten, Remy B Verheijen, Bart A W Jacobs, et al.
European Journal of Clinical Pharmacology
|
February 13, 2018
The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases
Bart A W Jacobs, Nikol Snoeren, Morsal Samim, et al.
Frontiers in Pharmacology
|
March 17, 2023
Access to medicines for rare diseases: A European regulatory roadmap for academia
Noa Rosenberg, Sibren van den Berg, Nina N Stolwijk, et al.
Cancer Chemotherapy and Pharmacology
|
March 1, 2024
Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data
Cedric Lau, Ma Ida Mohmaed Ali, Lishi Lin, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 26, 2019
Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis
Bart A W Jacobs, Maarten J Deenen, Markus Joerger, et al.
Journal of Inherited Metabolic Disease
|
March 7, 2026
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis
Natalja Bouwhuis, Soumia Majait, Yasmin Polak, et al.
Cancer Chemotherapy and Pharmacology
|
April 23, 2016
A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine
Bart A W Jacobs, Jelte Meulenaar, Hilde Rosing, et al.
Pharmaceutical Research
|
May 9, 2020
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Jeroen Roosendaal, Bart A W Jacobs, Dick Pluim, et al.
Bioanalysis
|
April 1, 2015
Improved pharmacodynamic assay for dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells
Dick Pluim, Bart A W Jacobs, Maarten J Deenen, et al.
Page
of 5